Is the Presence of a Depressive Disorder a Risk Factor for Worse Metabolic Outcomes Among Patients with Type 2 Diabetes Treated with GLP-1 Analogs?

Is the Presence of a Depressive Disorder a Risk Factor for Worse Metabolic Outcomes Among Patients with Type 2 Diabetes Treated with GLP-1 Analogs?

Background/Objectives: Type 2 diabetes mellitus (T2DM) is frequently associated with depressive disorder (DD), which negatively impacts glycemic control and overall metabolic outcomes. Recent evidence suggests that glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may exert neuroprotective effec...

Full description

Saved in:
Bibliographic Details
Main Authors: Joana Nicolau, Pilar Sanchís, María Isabel Tamayo, Guadalupe Pérez-Bec, Guido Sfondrini, Mireia Grimalt, Lluís Masmiquel
Format: Article
Language:English
Published: MDPI AG 2025-07-01
Series:Diabetology
Subjects:
type 2 diabetes
depressive disorder
GLP-1 analog
BMI
HbA1c
Online Access:https://www.mdpi.com/2673-4540/6/7/68
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items